Compliant
★★★★☆
Industry: Advanced Medical Equipment & Technology | NYSE
PerkinElmer Inc is Shariah compliant. The company’s financials pass four standards and fail in one.
| Market cap: 18,623 M | Rev. Growth: 74.65% |
AAOIFI ✓
| Debt/MC | 26.76% | ✓ |
| Non-Compliant Assets/MC | % |
| Impure Income (incl. Interest) | 0.04% | ✓ |
| Impure Income | % |
| Interest Income | 0.04% |
| Total | 0.04% |
S&P ✗
| Debt/36 mo MC | 33.97% | ✗ |
| Cash/36 mo MC | 4.21% | ✓ |
| AR/36 mo MC | 7.33% | ✓ |
DJIM ✓
| Debt/24 mo MC | 28.84% | ✓ |
| Cash/24 mo MC | 3.58% | ✓ |
| AR/24 mo MC | 6.22% | ✓ |
FTSE ✓
| Debt/Assets | 33.23% | ✓ |
| Cash/Assets | 4.12% | ✓ |
| Cash&AR/Assets | 11.29% | ✓ |
| Impure Income (incl. Interest) | 0.04% | ✓ |
| Impure Income | % |
| Interest Income | 0.04% |
| Total | 0.04% |
MSCI ✓
| Debt/Assets | 33.23% | ✓ |
| Cash/Assets | 4.12% | ✓ |
| Cash&AR/Assets | 11.29% | ✓ |
Recommendation Rating
1
2
3
4
5
1 = STRONG BUY | 2 = BUY | 3 = HOLD | 4 = UNDERPERFORM | 5 = SELL
Analysts’ Price Targets
Low: 125
High: 200
Total Analysts: 15
PerkinElmer, Inc. is a provider of products, services and solutions for the diagnostics, life sciences and applied markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment provides products and services targeted towards the life sciences and applied markets. The Diagnostics segment develops diagnostics, tools and applications focused on clinically oriented customers, especially within the reproductive health, immunodiagnostics and applied genomics markets. The Company provides early detection for genetic disorders from pregnancy to early childhood, and infectious disease testing for the diagnostics market. It offers its products under various brand names, including AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific, BoBs, chemagic, Chitas, Datalytix, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROline, EUROPattern, FragilEase, Genoglyphix, GSP, and others.
We do our best to screen stocks as accurately as possible. Please let us know in the comments if you spot an error or find something questionable. Jazaak Allahu khairan.
To understand how the screening is done, please read the Shariah Screening Methodology page.
Responses